Percutaneous Irreversible Electroporation for Downstaging and Control of Unresectable Pancreatic Adenocarcinoma-Reference-Cited by-同舟云学术

Percutaneous Irreversible Electroporation for Downstaging and Control of Unresectable Pancreatic Adenocarcinoma

Published:2012-12 Issue:12 Volume:23 Page:1613-1621
ISSN:1051-0443
Container-title:Journal of Vascular and Interventional Radiology
language:en
Short-container-title:Journal of Vascular and Interventional Radiology

Author:

Narayanan Govindarajan,Hosein Peter J.,Arora Geetika,Barbery Katuzka J.,Froud Tatiana,Livingstone Alan S.,Franceschi Dido,Rocha Lima Caio M.,Yrizarry Jose

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Reference29 articles.

1. Cancer Facts & Figures 2011;American Cancer Society,2011

2. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement;Callery;Ann Surg Oncol,2009

3. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages;Gillen;PLoS Med,2010

4. National Cancer Institute of Canada Clinical Trials Group. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group;Moore;J Clin Oncol,2007

5. Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular response to nanosecond pulses is milder in percutaneous ablation of hepatocellular carcinoma compared with microsecond pulses;Hepatobiliary & Pancreatic Diseases International;2024-06

2. Efficacy and safety of irreversible electroporation in unresectable perihilar cholangiocarcinoma: a systematic review and meta-analysis;British Journal of Radiology;2024-05-22

3. MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial;The Lancet Gastroenterology & Hepatology;2024-05

4. Irreversible electroporation to bring initially unresectable locally advanced pancreatic adenocarcinoma to surgery: the IRECAP phase II study;European Radiology;2024-03-18

5. Irreversible Electroporation of the Hepatobiliary System: Current Utilization and Future Avenues;Medicina;2024-01-31